Clinical trials
Observational Cutaneous Squamous Cell Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 3 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Recruiting | 6 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Maastricht University Medical Center | 5 |
| Queen Mary University of London | 2 |
| Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia | 1 |
| Corporacion Parc Tauli | 1 |
| EuMelaReg gGmbH | 1 |
| Massachusetts Eye and Ear Infirmary | 1 |
| Melanoma Institute Australia | 1 |
| Regeneron Pharmaceuticals | 1 |
| Ruhr University of Bochum | 1 |
| Sanofi | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cutaneous Squamous Cell Carcinoma | 19 |
| Basal Cell Carcinoma | 6 |
| Skin Neoplasms | 5 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Carcinoma, Merkel Cell | 2 |
| Carcinoma, Squamous Cell | 2 |
| Melanoma | 2 |
| Recurrence | 2 |
| Autoimmune Diseases | 1 |
| Bowen's Disease | 1 |
Trials
Showing 51 to 19 of 19. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.